A new study from UCLA reveals that artificial intelligence (AI) outperforms traditional medical professionals in detecting prostate cancer. The research, detailed in a press release from the university, found that an AI tool identified prostate cancer with 84% accuracy, compared to 67% accuracy achieved by physicians.

The AI software, Unfold AI, developed by Avenda Health in California and recently approved by the US Food and Drug Administration, utilizes an advanced algorithm to assess cancer likelihood from various clinical data sources.